Dr. Narang received his M.S. in Pharmaceutics from West Virginia University, and a Ph.D. in Pharmacokinetics from University of Maryland. He started his career at US National Institutes of Health after graduation. His career paths included leadership roles at Novartis, Pharmacia, GE (Medical Diagnostics), as well as Dr. Reddy’s (Biologics) in Regulatory, Quality, and Pharmacovigilance domains. Before expanding into the field of regulatory, Dr. Narang was the US Head of the Clinical Pharmacology/Pharmacokinetics group for Pharmacia. Most recently, he served as the VP of Scientific & Regulatory Strategy for a business focusing on leveraging 505(b)(2) NDA pathway. Dr. Narang brings more than 35 years of industrial experiences, not only in the scientific areas, but also in the global perspective with regulatory insights and scientific rigor into business decisions, R&D operations, and across development, marketing authorization, and brand protection. Dr. Narang is now the president of P.K. Narang Strategic Consulting providing advisory practices for life-science industry. He also serves in Advisory Board for several start-ups.